BE Therapeutics
Company

BE Therapeutics

Biotechnology Research New York, United States 6 employees
Employees
6
Contacts
1
Emails
1

BE Therapeutics Overview

Headquarters
New York, United States
Industry
Biotechnology Research
Employees
6
Founded
2023
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About BE Therapeutics

What if we could restore brain function for the tens of millions of individuals who suffer from permanent brain damage? Strokes, traumas, neurodegeneration, and tumors can all cause permanent brain damage, but as of now there are no treatments that enable affected individuals to regain lost abilities. Consequently, they remain dependent on costly care for the rest of their lives. The aim of the Brain Repair program is to develop methods for replacing damaged brain tissue, enabling patients to regain lost function. The success of BE Therapeutics will bring relief to the millions of people world-wide suffering from permanent brain damage.

BE Therapeutics Contact Details

People in AeroLeads
3
With contact data
1
Email contacts
1
33.3% coverage

BE Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Monika Hospodiuk Karwowski, Ph.d. Vascularization - Soft Tissue
View
Pascale Eede, Phd Life Science Vc - Associate
View
Wyndham Batchelor Senior Tissue Engineer (Senior
Email

Employees by Management Level

Senior / Lead 1 profile
Individual contributor 1 profile
Associate / junior 1 profile

Compare Similar Companies to BE Therapeutics